Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for preeclampsia prevention in high-risk pregnancies
NCT07087067Completed
- Sponsor
- Galala University
- Start
- Feb 2023
- Primary completion
- Feb 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin in preeclampsia (2 arms), sponsored by Galala University. Primary endpoint: Incidence of preeclampsia. Started Feb 2023; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT07087067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07087067.